PubMed:25854766
Annnotations
GoldHamster
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 27-34 | D027622 | denotes | saffron |
T1 | 27-34 | CHEBI:79068 | denotes | saffron |
T5 | 58-69 | 3639 | denotes | doxorubicin |
T3 | 58-69 | D004317 | denotes | doxorubicin |
T4 | 58-69 | CHEBI:64816 | denotes | doxorubicin |
T6 | 58-69 | CHEBI:28748 | denotes | doxorubicin |
T7 | 58-69 | D004317 | denotes | doxorubicin |
T9 | 91-97 | 813859 | denotes | rabbit |
T8 | 91-97 | D011817 | denotes | rabbit |
T10 | 91-97 | 9986 | denotes | rabbit |
T13 | 118-145 | D015427 | denotes | ischemia-reperfusion injury |
T14 | 118-145 | D015427 | denotes | ischemia-reperfusion injury |
T18 | 171-195 | CHEBI:49322 | denotes | anthracycline antibiotic |
T22 | 322-336 | D066126 | denotes | cardiotoxicity |
T23 | 322-336 | D066126 | denotes | cardiotoxicity |
T24 | 344-356 | CHEBI:26519 | denotes | free radical |
T26 | 450-457 | CHEBI:79068 | denotes | saffron |
T28 | 450-465 | D027622 | denotes | saffron (Crocus |
T29 | 450-465 | 82528 | denotes | saffron (Crocus |
T31 | 459-473 | D027622 | denotes | Crocus sativus |
T32 | 459-473 | 82528 | denotes | Crocus sativus |
T33 | 510-524 | D066126 | denotes | cardiotoxicity |
T34 | 510-524 | D066126 | denotes | cardiotoxicity |
T36 | 537-543 | 813859 | denotes | rabbit |
T35 | 537-543 | D011817 | denotes | rabbit |
T37 | 537-543 | 9986 | denotes | rabbit |
T38 | 567-570 | CVCL_E777 | denotes | min |
T39 | 578-586 | D007511 | denotes | ischemia |
T40 | 578-586 | D007511 | denotes | ischemia |
T41 | 596-601 | CVCL_XH58 | denotes | by 40 |
T42 | 602-605 | CVCL_E777 | denotes | min |
T44 | 673-680 | D027622 | denotes | saffron |
T43 | 673-680 | CHEBI:79068 | denotes | saffron |
T45 | 689-692 | CVCL_E777 | denotes | min |
T46 | 700-708 | D007511 | denotes | ischemia |
T47 | 700-708 | D007511 | denotes | ischemia |
T48 | 854-857 | PR:000029189 | denotes | AKT |
T49 | 854-857 | PR:P54644 | denotes | AKT |
T50 | 854-857 | PR:P31750 | denotes | AKT |
T51 | 854-857 | PR:000002190 | denotes | AKT |
T52 | 854-857 | Q8INB9 | denotes | AKT |
T53 | 858-862 | PR:A1Z8P9 | denotes | mTOR |
T54 | 858-862 | Q9JLN9 | denotes | mTOR |
T55 | 858-862 | PR:P42345 | denotes | mTOR |
T56 | 858-862 | P42346 | denotes | mTOR |
T57 | 858-862 | P42345 | denotes | mTOR |
T58 | 858-862 | PR:000003041 | denotes | mTOR |
T59 | 858-862 | PR:Q9JLN9 | denotes | mTOR |
T60 | 858-862 | PR:P42346 | denotes | mTOR |
T72 | 864-868 | PR:P50580 | denotes | EBP1 |
T73 | 864-868 | PR:000001754 | denotes | EBP1 |
T74 | 864-868 | PR:Q96327 | denotes | EBP1 |
T75 | 864-868 | PR:000012202 | denotes | EBP1 |
T76 | 864-868 | P25799 | denotes | EBP1 |
T77 | 864-868 | PR:Q9UQ80 | denotes | EBP1 |
T78 | 864-868 | P19838 | denotes | EBP1 |
T79 | 864-868 | Q63369 | denotes | EBP1 |
T80 | 869-876 | CHEBI:34922 | denotes | pathway |
T109 | 892-900 | O62618 | denotes | p38 MAPK |
T108 | 892-900 | D048051 | denotes | p38 MAPK |
T114 | 896-900 | GO:0004707 | denotes | MAPK |
T118 | 913-923 | Q9XZ71 | denotes | troponin T |
T120 | 913-923 | Q27371 | denotes | troponin T |
T119 | 913-923 | D020107 | denotes | troponin T |
T121 | 1011-1014 | CVCL_E777 | denotes | min |
T122 | 1049-1055 | UBERON:0000479 | denotes | tissue |
T124 | 1115-1122 | D027622 | denotes | saffron |
T123 | 1115-1122 | CHEBI:79068 | denotes | saffron |
T125 | 1264-1272 | D007511 | denotes | ischemia |
T126 | 1264-1272 | D007511 | denotes | ischemia |
T128 | 1321-1328 | D027622 | denotes | saffron |
T127 | 1321-1328 | CHEBI:79068 | denotes | saffron |
T130 | 1362-1372 | Q9XZ71 | denotes | troponin T |
T132 | 1362-1372 | Q27371 | denotes | troponin T |
T131 | 1362-1372 | D020107 | denotes | troponin T |
T133 | 1373-1381 | CHEBI:36080 | denotes | proteins |
T162 | 1397-1405 | O62618 | denotes | p38 MAPK |
T161 | 1397-1405 | D048051 | denotes | p38 MAPK |
T167 | 1401-1405 | GO:0004707 | denotes | MAPK |
T170 | 1406-1413 | CHEBI:34922 | denotes | pathway |
T171 | 1433-1436 | PR:000029189 | denotes | AKT |
T172 | 1433-1436 | PR:P54644 | denotes | AKT |
T173 | 1433-1436 | PR:P31750 | denotes | AKT |
T174 | 1433-1436 | PR:000002190 | denotes | AKT |
T175 | 1433-1436 | Q8INB9 | denotes | AKT |
T176 | 1437-1441 | PR:A1Z8P9 | denotes | mTOR |
T177 | 1437-1441 | Q9JLN9 | denotes | mTOR |
T178 | 1437-1441 | PR:P42345 | denotes | mTOR |
T179 | 1437-1441 | P42346 | denotes | mTOR |
T180 | 1437-1441 | P42345 | denotes | mTOR |
T181 | 1437-1441 | PR:000003041 | denotes | mTOR |
T182 | 1437-1441 | PR:Q9JLN9 | denotes | mTOR |
T183 | 1437-1441 | PR:P42346 | denotes | mTOR |
T195 | 1443-1447 | PR:P50580 | denotes | EBP1 |
T196 | 1443-1447 | PR:000001754 | denotes | EBP1 |
T197 | 1443-1447 | PR:Q96327 | denotes | EBP1 |
T198 | 1443-1447 | PR:000012202 | denotes | EBP1 |
T199 | 1443-1447 | P25799 | denotes | EBP1 |
T200 | 1443-1447 | PR:Q9UQ80 | denotes | EBP1 |
T201 | 1443-1447 | P19838 | denotes | EBP1 |
T202 | 1443-1447 | Q63369 | denotes | EBP1 |
T203 | 1448-1455 | CHEBI:34922 | denotes | pathway |
T204 | 1488-1494 | D011817 | denotes | rabbit |
T206 | 1488-1494 | 9986 | denotes | rabbit |
T205 | 1488-1494 | 813859 | denotes | rabbit |
T208 | 1518-1525 | D027622 | denotes | saffron |
T207 | 1518-1525 | CHEBI:79068 | denotes | saffron |
T209 | 1551-1562 | CHEBI:22586 | denotes | antioxidant |
T210 | 1643-1657 | D066126 | denotes | cardiotoxicity |
T211 | 1643-1657 | D066126 | denotes | cardiotoxicity |
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 147-274 | DRI_Background | denotes | Doxorubicin (DOX) is an anthracycline antibiotic routinely used as a chemotherapeutic agent for the treatment of solid tumours. |
T2 | 275-368 | DRI_Background | denotes | However, DOX possesses an acute and cumulative cardiotoxicity due to free radical production. |
T3 | 369-618 | DRI_Background | denotes | The present study was designed to investigate the possible protective effects of saffron (Crocus sativus) extracts against DOX-induced acute cardiotoxicity in isolated rabbit hearts submitted to 30 min global ischemia followed by 40 min reperfusion. |
T4 | 619-727 | DRI_Background | denotes | DOX was delivered during reperfusion, without or with saffron given 5 min before ischemia or at reperfusion. |
T5 | 728-805 | DRI_Background | denotes | Cardiodynamic, biochemical, and histopathological parameters were determined. |
T6 | 806-981 | DRI_Outcome | denotes | In addition, to determine the expression of the AKT/mTOR/4EBP1 pathway, the levels of p38 MAPK and cardiac troponin T in heart homogenates were visualized by Western blotting. |
T7 | 982-1096 | DRI_Background | denotes | DOX administration during 40 min of reperfusion increased ischemic tissue damage, but did not act synergistically. |
T8 | 1097-1273 | DRI_Outcome | denotes | Administration of saffron extracts during the first minutes of reperfusion significantly reduced oxidative myocardial damage, but was less effective when given before ischemia. |
T9 | 1274-1502 | DRI_Outcome | denotes | Subsequent Western blot analysis revealed that saffron administration preserved cardiac troponin T proteins, inhibited the p38 MAPK pathway, and activated the AKT/mTOR/4EBP1 pathway in reperfusion- and DOX-treated rabbit hearts. |
T10 | 1503-1683 | DRI_Background | denotes | In conclusion, saffron extracts, acting through antioxidant and antiapoptotic mechanisms, exhibited a protective effect against DOX-induced cardiotoxicity under ischemic condition. |
Goldhamster2_Cellosaurus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 168-170 | CVCL_8754|Cancer_cell_line|Homo sapiens | denotes | an |
T2 | 168-170 | CVCL_H241|Cancer_cell_line|Homo sapiens | denotes | an |
T3 | 214-215 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T4 | 298-300 | CVCL_8754|Cancer_cell_line|Homo sapiens | denotes | an |
T5 | 298-300 | CVCL_H241|Cancer_cell_line|Homo sapiens | denotes | an |
T6 | 564-566 | CVCL_J925|Hybridoma|Mus musculus | denotes | 30 |
T7 | 567-570 | CVCL_E777|Transformed_cell_line|Homo sapiens | denotes | min |
T8 | 599-601 | CVCL_IW90|Cancer_cell_line|Mus musculus | denotes | 40 |
T9 | 602-605 | CVCL_E777|Transformed_cell_line|Homo sapiens | denotes | min |
T10 | 689-692 | CVCL_E777|Transformed_cell_line|Homo sapiens | denotes | min |
T11 | 1008-1010 | CVCL_IW90|Cancer_cell_line|Mus musculus | denotes | 40 |
T12 | 1011-1014 | CVCL_E777|Transformed_cell_line|Homo sapiens | denotes | min |
T13 | 1419-1428 | CVCL_C410|Hybridoma|Mus musculus | denotes | activated |
T14 | 1603-1604 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 266-273 | HP_0002664 | denotes | tumours |